Toggle navigation
MENU
LOGIN
DONATE +
About
Why AIM
Leadership Society
Corporate Champions
Board/Staff
Contact Us
Issues
Research
Care
Support
Priorities
Federal
State
TAKE ACTION
Act Now
Congressional Profiles
Join AIM
Become an
Advocacy Volunteer
Report an Action
News
Blog
Statements
Weekly Roundup
COVID-19
JOIN AIM
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
AIM BLOG POSTS
Pathway to Treatments Through Accelerated Approvals
Apr 27, 2022 |
By Elise Argall
Read More
Securing Critical Funding for Alzheimer’s and Other Dementia Research
Mar 30, 2022 |
By Rachel Conant
Read More
Thank You Advocates for Advancing Our Mission
Feb 18, 2022 |
By Elise Argall
Read More
For Individuals with Early-Stage Alzheimer’s Disease: A Decision With Devastating Repercussions
Feb 15, 2022 |
By Elise Argall
Read More
Patient Perspective: The Clock is Ticking for People Living with Alzheimer’s
Feb 9, 2022 |
By Elise Argall
Read More
Fighting for Folks Like Me
Feb 2, 2022 |
By Dan Jaworski
Read More
Load More
Why AIM
Corporate Members
Leadership
Help
Contact Us
Research
Care
Support
Federal
State
Act Now
Join AIM
Become an
Advocacy Volunteer
Members of Congress
Blog
Statements
Weekly Roundup
